The European Medicines Agency (EMA) Emergency Working Group (ETF) has recommended updating the composition of Covid-19 vaccines to address the new XFG variant of SARS-CoV-2 in the next vaccination campaign 2026/2027.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The European Medicines Agency (EMA) Emergency Working Group (ETF) has recommended updating the composition of Covid-19 vaccines to address the new XFG variant of SARS-CoV-2 in the next vaccination campaign 2026/2027.